15.51
price down icon0.45%   -0.07
after-market After Hours: 15.64 0.13 +0.84%
loading
Teva Pharmaceutical Industries Ltd Adr stock is traded at $15.51, with a volume of 8.89M. It is down -0.45% in the last 24 hours and up +0.91% over the past month. Teva Pharmaceutical Industries, based in Israel, is the leading generic drug manufacturer in the world. Teva derives half of its sales from North America and makes up a high-single-digit percentage of the total number of generic prescriptions in the US. It also has a significant presence in Europe, Japan, Russia, and Israel. Besides generics, Teva has a portfolio of innovative medicines and biosimilars in three main therapeutic areas: the central nervous system with Copaxone, Ajovy, and Austedo; respiratory with Qvar and ProAir; and oncology with Truxima, Herzuma, and Bendeka/Treanda. Teva also sells active pharmaceutical ingredients, offers contract manufacturing services, and owns Anda, a US-based generic and specialty drug distributor.
See More
Previous Close:
$15.58
Open:
$15.53
24h Volume:
8.89M
Relative Volume:
0.73
Market Cap:
$17.76B
Revenue:
$16.54B
Net Income/Loss:
$-1.64B
P/E Ratio:
-10.70
EPS:
-1.45
Net Cash Flow:
$749.00M
1W Performance:
+8.54%
1M Performance:
+0.91%
6M Performance:
-15.89%
1Y Performance:
+10.39%
1-Day Range:
Value
$15.31
$15.62
1-Week Range:
Value
$14.16
$15.72
52-Week Range:
Value
$12.46
$22.80

Teva Pharmaceutical Industries Ltd Adr Stock (TEVA) Company Profile

Name
Name
Teva Pharmaceutical Industries Ltd Adr
Name
Phone
972 (3) 914-8213
Name
Address
TEVA PHARMACEUTICAL INDUSTRIES LIMITED, TEL AVIV
Name
Employee
35,686
Name
Twitter
@TevaUSA
Name
Next Earnings Date
2025-01-29
Name
Latest SEC Filings
Name
TEVA's Discussions on Twitter

Compare TEVA with other stocks

Stocks Price Market Cap Revenue Net Income Cash Flow EPS
Drug Manufacturers - Specialty & Generic icon
TEVA
Teva Pharmaceutical Industries Ltd Adr
15.51 17.76B 16.54B -1.64B 749.00M -1.45
Drug Manufacturers - Specialty & Generic icon
ZTS
Zoetis Inc
156.40 67.32B 9.26B 2.49B 2.30B 5.47
Drug Manufacturers - Specialty & Generic icon
TAK
Takeda Pharmaceutical Co Adr
15.29 47.78B 30.25B 1.37B 5.08B 0.4257
Drug Manufacturers - Specialty & Generic icon
HLN
Haleon Plc Adr
10.15 46.14B 14.35B 1.85B 0 0.4023
Drug Manufacturers - Specialty & Generic icon
UTHR
United Therapeutics Corp
303.09 13.18B 2.76B 1.11B 898.10M 22.77

Teva Pharmaceutical Industries Ltd Adr Stock (TEVA) Upgrades & Downgrades

Date Action Analyst Rating Change
Jul-10-24 Upgrade Argus Hold → Buy
Mar-08-24 Upgrade JP Morgan Underweight → Neutral
Feb-12-24 Upgrade Piper Sandler Neutral → Overweight
Jan-23-24 Upgrade Jefferies Hold → Buy
Jan-03-24 Upgrade Piper Sandler Underweight → Neutral
Dec-18-23 Initiated HSBC Securities Buy
Nov-27-23 Upgrade UBS Neutral → Buy
Jul-06-23 Upgrade UBS Sell → Neutral
May-25-23 Initiated Morgan Stanley Equal-Weight
May-18-23 Upgrade Evercore ISI In-line → Outperform
Jan-19-23 Downgrade Jefferies Buy → Hold
Nov-14-22 Downgrade JP Morgan Neutral → Underweight
Nov-04-22 Downgrade UBS Neutral → Sell
Oct-21-22 Resumed Jefferies Buy
Aug-05-22 Upgrade BofA Securities Neutral → Buy
Jun-14-22 Resumed UBS Neutral
May-17-22 Upgrade BofA Securities Underperform → Neutral
May-04-22 Downgrade Piper Sandler Neutral → Underweight
Apr-05-22 Upgrade Barclays Equal Weight → Overweight
Mar-25-22 Upgrade Bernstein Mkt Perform → Outperform
Jan-27-22 Downgrade Argus Buy → Hold
Oct-28-21 Downgrade Raymond James Outperform → Mkt Perform
May-04-21 Downgrade UBS Buy → Neutral
Apr-07-21 Resumed RBC Capital Mkts Sector Perform
Nov-25-20 Initiated Oppenheimer Perform
Aug-06-20 Upgrade Barclays Underweight → Equal Weight
Jul-27-20 Resumed Goldman Neutral
Jun-01-20 Upgrade SunTrust Hold → Buy
Apr-24-20 Resumed Citigroup Neutral
Apr-06-20 Upgrade UBS Neutral → Buy
Feb-24-20 Downgrade Edward Jones Hold → Sell
Nov-12-19 Upgrade JP Morgan Underweight → Neutral
Oct-17-19 Upgrade Gabelli & Co Hold → Buy
Aug-07-19 Downgrade Evercore ISI Outperform → In-line
Jul-19-19 Initiated Wolfe Research Peer Perform
Jul-15-19 Downgrade Morgan Stanley Equal-Weight → Underweight
Jul-10-19 Resumed Credit Suisse Neutral
Jul-05-19 Upgrade Argus Hold → Buy
Jun-11-19 Initiated Barclays Underweight
Jun-03-19 Upgrade Oppenheimer Perform → Outperform
May-30-19 Downgrade BofA/Merrill Buy → Underperform
May-28-19 Downgrade UBS Buy → Neutral
Mar-20-19 Initiated SunTrust Hold
Mar-07-19 Resumed UBS Buy
View All

Teva Pharmaceutical Industries Ltd Adr Stock (TEVA) Latest News

pulisher
Apr 30, 2025

There Are Mixed Signals on the Chart for Teva- Pharmaceutical Industries Ltd. ADR (TEVA) - uspostnews.com

Apr 30, 2025
pulisher
Apr 30, 2025

Digi Power X Inc (DGXX)’s highs and lows: A closer look at its stock price fluctuations - uspostnews.com

Apr 30, 2025
pulisher
Apr 29, 2025

Market Analysts see Norwegian Cruise Line Holdings Ltd [NCLH] gaining to $21. Time to buy? - dbtnews.com

Apr 29, 2025
pulisher
Apr 29, 2025

PG&E Corp [PCG] Revenue clocked in at $24.54 billion, down -14.37% YTD: What’s Next? - dbtnews.com

Apr 29, 2025
pulisher
Apr 29, 2025

Greenwave Technology Solutions Inc [GWAV] Is Currently 12.13 above its 200 Period Moving Avg: What Does This Mean? – The DBT News - dbtnews.com

Apr 29, 2025
pulisher
Apr 29, 2025

Teva- Pharmaceutical Industries Ltd. ADR (TEVA) Performance and Fundamentals Dashboard tells a completely different story – Sete News - Sete News

Apr 29, 2025
pulisher
Apr 28, 2025

Teva- Pharmaceutical Industries Ltd. ADR (TEVA) Stock: A Year of Highs and Lows - investchronicle.com

Apr 28, 2025
pulisher
Apr 28, 2025

Company’s Banking Stock: Dissecting a 37.52% Quarterly Revenue Decline Amid Growth - investchronicle.com

Apr 28, 2025
pulisher
Apr 28, 2025

NEOV’s Market Whiplash: -48.46% YTD Decline, 15.24% Rise in 30 Days - investchronicle.com

Apr 28, 2025
pulisher
Apr 28, 2025

Adagio Medical Holdings Inc (ADGM) Stock: Uncovering a 52-Week Range and Trading Volume - investchronicle.com

Apr 28, 2025
pulisher
Apr 25, 2025

A company insider recently sold 70,961 shares of Teva- Pharmaceutical Industries Ltd. ADR [TEVA]. Should You Sale? - knoxdaily.com

Apr 25, 2025
pulisher
Apr 24, 2025

Introducing Our Rant Against Teva- Pharmaceutical Industries Ltd. ADR - uspostnews.com

Apr 24, 2025
pulisher
Apr 24, 2025

OS overperforms with a 2.12 increase in share price - uspostnews.com

Apr 24, 2025
pulisher
Apr 23, 2025

For Kopin Corp [KOPN], Analyst sees a rise to $2. What next? - dbtnews.com

Apr 23, 2025
pulisher
Apr 23, 2025

Market Analysts see Geron Corp [GERN] falling to $2. Time to buy? - dbtnews.com

Apr 23, 2025
pulisher
Apr 23, 2025

Teva- Pharmaceutical Industries Ltd. ADR [TEVA] Is Currently 5.18 below its 200 Period Moving Avg: What Does This Mean? – The DBT News - dbtnews.com

Apr 23, 2025
pulisher
Apr 22, 2025

The growth track for Teva- Pharmaceutical Industries Ltd. ADR (TEVA) has changed recently - Sete News

Apr 22, 2025
pulisher
Apr 22, 2025

Rezolute Inc: Weathering Stock Market Storms with 190.08M Market Cap - investchronicle.com

Apr 22, 2025
pulisher
Apr 22, 2025

Ready to Jump After Recent Trade: NIO Inc ADR (NIO) - Sete News

Apr 22, 2025
pulisher
Apr 21, 2025

Teva- Pharmaceutical Industries Ltd. ADR (TEVA) Stock: Exploring a Year of Highs, Lows, and Trading Volume - investchronicle.com

Apr 21, 2025
pulisher
Apr 21, 2025

ORCL’s Stock Journey: What Investors Need to Know About Oracle Corp’s Performance - investchronicle.com

Apr 21, 2025
pulisher
Apr 21, 2025

TGB Stock Update: Taseko Mines Ltd’s Banking’s Market Struggles and Potential Opportunities - investchronicle.com

Apr 21, 2025
pulisher
Apr 21, 2025

Lexicon Pharmaceuticals Inc (LXRX) Stock: A Year of Market Fluctuations - investchronicle.com

Apr 21, 2025
pulisher
Apr 21, 2025

HESM’s latest rating updates from top analysts. - knoxdaily.com

Apr 21, 2025
pulisher
Apr 21, 2025

Analysts review Teva- Pharmaceutical Industries Ltd. ADR’s rating - knoxdaily.com

Apr 21, 2025
pulisher
Apr 21, 2025

Trump Tariff Sell-Off: 3 Superb Stocks That Make for No-Brainer Buys Right Now - The Motley Fool

Apr 21, 2025
pulisher
Apr 16, 2025

Zacks Industry Outlook Dr. Reddy's, Sandoz And Teva Pharmaceuticals - Barchart.com

Apr 16, 2025
pulisher
Apr 02, 2025

Is Vera Therapeutics Inc (VERA) a threat to investors? - uspostnews.com

Apr 02, 2025
pulisher
Apr 02, 2025

What technical indicators reveal about MYGN stock - uspostnews.com

Apr 02, 2025
pulisher
Apr 02, 2025

VF Corp (VFC) is a good investment, but the stock may be overvalued - uspostnews.com

Apr 02, 2025
pulisher
Apr 02, 2025

Investing in Calumet Inc (CLMT) might be an excellent idea, but the stock is currently overvalued/undervalued - uspostnews.com

Apr 02, 2025
pulisher
Apr 02, 2025

Wabash National Corp (WNC) stock on the rise: An overview - uspostnews.com

Apr 02, 2025
pulisher
Apr 02, 2025

The Gryphon Digital Mining Inc (GRYP) had a good session last reading, didn’t it? - uspostnews.com

Apr 02, 2025
pulisher
Apr 02, 2025

Generics Industry: India Celebrates Pharmaceutical Tariffs Exemption but Uncertainty Remains High - Morningstar

Apr 02, 2025
pulisher
Mar 27, 2025

What will the future hold for CarGurus Inc (NASDAQ:CARG) stock? - US Post News

Mar 27, 2025
pulisher
Mar 25, 2025

TEVA’s Market Seesaw: Yearly Gains & Recent Declines – What to Expect? - investchronicle.com

Mar 25, 2025
pulisher
Mar 18, 2025

Teva Pharmaceutical Stock Scores RS Rating Upgrade - MSN

Mar 18, 2025
pulisher
Mar 18, 2025

IBD Rating Upgrades: Teva Pharmaceutical ADR Flashes Improved Relative Price Strength - Investor's Business Daily

Mar 18, 2025
pulisher
Mar 17, 2025

Weekly Stock Grader Analysis: Upgrades & Downgrades on Top Blue-Chip Stocks - InvestorPlace

Mar 17, 2025
pulisher
Mar 07, 2025

How does TEVA’s price to cash per share ratio compare in the market? - US Post News

Mar 07, 2025
pulisher
Mar 06, 2025

Teva Pharmaceutical Industries Limited Sponsored ADR to Host Earnings Call - ACCESS Newswire

Mar 06, 2025
pulisher
Mar 03, 2025

Validea Detailed Fundamental AnalysisTEVA - Nasdaq

Mar 03, 2025
pulisher
Mar 03, 2025

Why weight-loss drugs are the top target of Medicare price negotiations - Equities News

Mar 03, 2025
pulisher
Feb 27, 2025

Investor Network: Teva Pharmaceutical Industries Limited Sponsored ADR to Host Earnings Call - ACCESS Newswire

Feb 27, 2025
pulisher
Feb 27, 2025

Is the SM Energy Co (NYSE:SM) stock an investment opportunity? - US Post News

Feb 27, 2025
pulisher
Feb 27, 2025

Teva Pharmaceutical Stock: Strategic Global Access Initiatives Advance - sharewise

Feb 27, 2025
pulisher
Feb 27, 2025

Are Clear Secure Inc’shares a good deal? - US Post News

Feb 27, 2025
pulisher
Feb 27, 2025

Molina Healthcare Inc (MOH) stock on the rise: An overview - US Post News

Feb 27, 2025
pulisher
Feb 23, 2025

Stocktwits teva sales - Texas is Life

Feb 23, 2025
pulisher
Feb 11, 2025

Teva- Pharmaceutical Industries Ltd. ADR’s: Contrasting Stock Performances in a Volatile Market - The InvestChronicle

Feb 11, 2025
pulisher
Feb 11, 2025

FHN’s Stock Market Expedition: Traversing Gains and Losses in 2023 - The InvestChronicle

Feb 11, 2025

Teva Pharmaceutical Industries Ltd Adr Stock (TEVA) Financials Data

Revenue

loading

Net Income

loading

Cash Flow

loading

EPS

loading
$303.09
price up icon 0.77%
$107.69
price up icon 0.42%
$8.42
price up icon 0.96%
$104.34
price up icon 0.37%
$9.48
price down icon 2.67%
Cap:     |  Volume (24h):